AbbVie's Life After Abbott DailyFinance One of the drugs the company pins future hopes on is daclizumab, which is used to treat relapsing multiple sclerosis. A phase 3 clinical trial is currently under way for the drug in collaboration with Biogen . Results from this study are expected in ... |
